- Home
- BWAY vs TVGN Comparison
BWAY vs TVGN Comparison
Compare BWAY & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWAY
- TVGN
- Stock Information
- Founded
- BWAY 2003
- TVGN 2020
- Country
- BWAY Israel
- TVGN United States
- Employees
- BWAY N/A
- TVGN N/A
- Industry
- BWAY Medical/Dental Instruments
- TVGN Blank Checks
- Sector
- BWAY Health Care
- TVGN Finance
- Exchange
- BWAY Nasdaq
- TVGN Nasdaq
- Market Cap
- BWAY 201.1M
- TVGN 193.1M
- IPO Year
- BWAY 2019
- TVGN N/A
- Fundamental
- Price
- BWAY $10.96
- TVGN $1.20
- Analyst Decision
- BWAY Strong Buy
- TVGN Strong Buy
- Analyst Count
- BWAY 2
- TVGN 1
- Target Price
- BWAY $14.25
- TVGN $10.00
- AVG Volume (30 Days)
- BWAY 33.7K
- TVGN 817.5K
- Earning Date
- BWAY 08-05-2025
- TVGN 08-13-2025
- Dividend Yield
- BWAY N/A
- TVGN N/A
- EPS Growth
- BWAY N/A
- TVGN N/A
- EPS
- BWAY 0.08
- TVGN N/A
- Revenue
- BWAY $43,457,000.00
- TVGN N/A
- Revenue This Year
- BWAY $351.53
- TVGN N/A
- Revenue Next Year
- BWAY $21.84
- TVGN N/A
- P/E Ratio
- BWAY $54.48
- TVGN N/A
- Revenue Growth
- BWAY 26.86
- TVGN N/A
- 52 Week Low
- BWAY $5.67
- TVGN $0.26
- 52 Week High
- BWAY $12.00
- TVGN $3.09
- Technical
- Relative Strength Index (RSI)
- BWAY 58.38
- TVGN 48.04
- Support Level
- BWAY $10.81
- TVGN $1.09
- Resistance Level
- BWAY $11.40
- TVGN $1.31
- Average True Range (ATR)
- BWAY 0.46
- TVGN 0.10
- MACD
- BWAY -0.03
- TVGN -0.02
- Stochastic Oscillator
- BWAY 50.88
- TVGN 26.19
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.